Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study
- PMID: 22826107
- DOI: 10.1001/archinternmed.2012.2713
Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study
Abstract
Background: Limited evidence suggests that the risk of acute myocardial infarction (AMI) may be increased shortly after total hip replacement (THR) and total knee replacement (TKR) surgery. However, risk of AMI in these patients has not been compared against matched controls who have not undergone surgery. The objective of this study was to evaluate the timing of AMI in patients undergoing THR or TKR surgery compared with matched controls.
Methods: Retrospective, nationwide cohort study within the Danish national registries. All patients who underwent a primary THR or TKR (n = 95,227) surgery from January 1, 1998, through December 31, 2007, were selected and matched to 3 controls (no THR or TKR) by age, sex, and geographic region. All study participants were followed up for AMI, and disease- and medication history-adjusted hazard ratios (HRs) were calculated.
Results: During the first 2 postoperative weeks, the risk of AMI was substantially increased in THR patients compared with controls (adjusted HR, 25.5; 95% CI, 17.1-37.9). The risk remained elevated for 2 to 6 weeks after surgery (adjusted HR, 5.05; 95% CI, 3.58-7.13) and then decreased to baseline levels. For TKR patients, AMI risk was also increased during the first 2 weeks (adjusted HR, 30.9; 95% CI, 11.1-85.5) but did not differ from controls after the first 2 weeks. The absolute 6-week risk of AMI was 0.51% in THR patients and 0.21% in TKR patients.
Conclusions: Risk of AMI is substantially increased in the first 2 weeks after THR (25-fold) and TKR (31-fold) surgery compared with controls. Risk assessment of AMI should be considered during the first 6 weeks after THR surgery and during the first 2 weeks after TKR surgery.
Comment in
-
Risk of acute myocardial infarction in patients with total hip or knee replacement: comment on "Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study".Arch Intern Med. 2012 Sep 10;172(16):1235-6. doi: 10.1001/archinternmed.2012.3776. Arch Intern Med. 2012. PMID: 22825029 No abstract available.
Similar articles
-
Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls: a nationwide cohort study.Am J Gastroenterol. 2013 Aug;108(8):1277-85. doi: 10.1038/ajg.2013.108. Epub 2013 Apr 30. Am J Gastroenterol. 2013. PMID: 23629603
-
Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.J Med Econ. 2011;14(3):324-34. doi: 10.3111/13696998.2011.578698. Epub 2011 Apr 20. J Med Econ. 2011. PMID: 21506632
-
Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement.J Thromb Haemost. 2013 Apr;11(4):642-50. doi: 10.1111/jth.12158. J Thromb Haemost. 2013. PMID: 23387806
-
Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.Semin Vasc Med. 2005 Aug;5(3):266-75. doi: 10.1055/s-2005-916166. Semin Vasc Med. 2005. PMID: 16123914 Review.
-
Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.Health Technol Assess. 2009 Oct;13 Suppl 3:43-8. doi: 10.3310/hta13suppl3/07. Health Technol Assess. 2009. PMID: 19846028 Review.
Cited by
-
Impact of diabetic kidney disease on post-operative complications after primary elective total hip arthroplasty: a nationwide database analysis.BMC Musculoskelet Disord. 2024 Jul 16;25(1):551. doi: 10.1186/s12891-024-07653-1. BMC Musculoskelet Disord. 2024. PMID: 39014378 Free PMC article.
-
Simultaneous bilateral total hip arthroplasty-a survey of Irish orthopaedic surgeons' practice.Ir J Med Sci. 2024 Oct;193(5):2349-2354. doi: 10.1007/s11845-024-03726-1. Epub 2024 Jun 5. Ir J Med Sci. 2024. PMID: 38837013 Free PMC article.
-
Risk factors for in-patient myocardial infarction following total hip arthroplasty.J Orthop. 2024 Jan 12;51:60-65. doi: 10.1016/j.jor.2024.01.007. eCollection 2024 May. J Orthop. 2024. PMID: 38313428
-
Cellular and Molecular Mechanisms of Mast Cells in Atherosclerotic Plaque Progression and Destabilization.Clin Rev Allergy Immunol. 2024 Feb;66(1):30-49. doi: 10.1007/s12016-024-08981-9. Epub 2024 Jan 30. Clin Rev Allergy Immunol. 2024. PMID: 38289515 Free PMC article. Review.
-
Timing of adverse events in patients undergoing acute and elective hip arthroplasty surgery: a multicentre cohort study using the Global Trigger Tool.BMJ Open. 2023 Jun 9;13(6):e064794. doi: 10.1136/bmjopen-2022-064794. BMJ Open. 2023. PMID: 37295831 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
